Market News & Trends
Caladrius Biosciences Subsidiary Enters Into Global Collaboration & License Agreement
Caladrius Biosciences, Inc. recently announced that, through its subsidiary, PCT, has entered into a global collaboration with Hitachi Chemical Co., Ltd. that includes licensing, development,…
Ajinomoto Althea Expands Capacity of Fill Finish Manufacturing
Ajinomoto Althea, Inc. recently announced it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift. Althea's…
Ascendia Pharma Announces New Contract Manufacturing Capability to Deliver cGMP Phase I Clinical Trial Materials
Ascendia now offers cGMP manufacturing capabilities for both oral and parenteral dosage forms to support your Phase I clinical trials. We have recently finished the qualification…
Gastric Cancer Drug Development Shifting From Small Molecules to Monoclonal Antibodies
While 99% of currently marketed gastric cancer drugs are small molecules, this dominance could give way to more innovative treatments in future, as the pipeline…
Formulation Development Success Story: Uric Acid Treatment Approved by FDA
The U.S. Food and Drug Administration recently approved a new uric acid treatment that was developed as a partnership between Metrics Contract Services and the…
Glioblastoma Treatment Hopes Turn to Combining Peptide Vaccines With Immuno-Oncology Products
The termination of Celldex’s Phase III trial assessing its peptide-based vaccine therapy, Rintega, in newly diagnosed glioblastoma patients, represents a blow to the treatment space…
Immunomedics Develops Novel Antibody-Based Products for Autoimmune Disease & Cancer Therapy
Immunomedics, Inc. recently announced that the issuance of US Patent No. 9,278,129 for the company’s new patent family Methods of Treating Rapidly Progressive Glomerulonephritis Using…
DPT & Confab Complete $10-Million Capital Investment
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid dosage forms, and Confab, a DPT company specializing in complex solids,…
MilliporeSigma Launches New Innovations
The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the US and Canada, launched a range of new products for…
Crown Bioscience Acquires PreClinOmics, Expands Cardiovascular & Metabolic Disease Portfolio
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology…
Topi-CLICK Revealed as Most Accurate Topical Metered-Dosing Dispenser in Independent Study
Since introducing Topi-CLICK in 2007, DoseLogix has emphasized superior accuracy and precision compared to other topical metered-dosing dispensers. Now there is scientific research to confirm…
Foster Introduces ProFlex for Soft Touch Medical Devices
Foster Corporation recently announced the introduction of ProFlex styrene-ethylene butylene-styrene (SEBS) for medical device applications. These polymers offer a low-cost alternative to other thermoplastic elastomers…
Synexus Expands Global Capability & Enters US Market
Synexus recently announced the purchase of Research Across America for an undisclosed sum. RAA was founded by Dr. Jeffrey Adelglass and has proven clinical trial…
EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals
Eyegate Pharmaceuticals, Inc. recently announced that it has received an additional development milestone from Valeant Pharmaceuticals Luxembourg under the company's license agreement with Valeant for…
BIOCORP Wins Pharmapack Award for Smart Sensor, Easylog
BIOCORP, a French company specializing in the development and manufacturing of innovative medical and drug delivery devices, recently announced it has won the Best Exhibitor…
Nanosphere Announces Significate Study Results
Nanosphere, Inc. recently announced publication of a study that demonstrates the clinical and economic impact of implementing rapid sepsis diagnostic testing with the company’s FDA-cleared…
Acticor Biotech Selects Catalent GPEx Cell Line Development Technology
Acticor Biotech recently announced it has selected Catalent’s proprietary GPEx technology for the development of its Fab candidate, ACT-017, targeting the platelet glycoprotein VI (GPVI).…
Gensco Laboratories Launches First Transdermal Medication for Acute Gout Flares
Gensco Laboratories recently announced ColciGel, a new transdermal medication indicated for the treatment of acute gout flares in adults. Gout is an extremely painful form…
Nitrogen Dioxide Sterilization: Maintains Prefilled Syringe Integrity
Noxilizer has developed an optimal sterilization process specifically for prefilled syringes and other drug-delivery devices. The low temperature NO2 sterilization process will effectively sterilize the…
Strong Life Sciences Sector Will Drive UK Pharmaceutical Market to $43 Billion
The pharmaceutical market in the UK is set to grow from $28.8 billion in 2015 to approximately $43 billion by 2020, representing a Compound Annual…